You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Overactive bladder (OAB) is a common condition that prevents you from controlling when and how much you urinate. If you have OAB, you might experience one or more of the following:
If you have bladder control issues, you’re not alone. Millions of people in senior living facilities are in the same situation. In fact, more than 70% of long-term care residents are not in complete control of their urinary bladder function.1
OAB is not a normal part of aging. It’s a treatable condition. And there is a safe and effective way to treat it — right where you live.
Medications known as anticholinergics are a common treatment option for OAB. However, if you’re already taking drugs for other medical conditions, you may not be a candidate for OAB medication due to possible interactions with your current medications.2,3
A therapy called percutaneous tibial neuromodulation (PTNM), delivered by the NUROTM system, can help you take back control of your bladder — and your life. It doesn’t cause side effects* like medications can.4
The most common side effects of PTNM are temporary and include mild pain or skin inflammation at or near the stimulation site.
Gorina Y, Schappert S, Bercovitz A, et al. Prevalence of incontinence among older Americans. Vital Health Stat 3. 2014;(36):1-33
Gray S, Anderson M, Dublin S et al. Cumulative Use of Strong Anticholinergics and Incident Dementia. JAMA Intern Med. 2015;175(3):401-407.
Campanelli CM. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults: The American Geriatrics Society 2012 Beers Criteria update expert panel. J Am Geriatr Soc. 2012 April;60(4):616–631.
CMS Manual System. Department of Health & Human Services. Dec 2016. Pgs. 291-326.